MENU

Can Altria Group (MO) Stock Reach $85?

a holding company which produces and markets tobacco products

Industry: #Tobacco
A.I.Advisor
published price charts
A.I.Advisor
Oct 30, 2026

Can Altria Group (MO) Stock Reach $85?

Altria Group, Inc. (MO), the Richmond, Virginia-based maker of Marlboro cigarettes, Copenhagen and Skoal oral tobacco, and the on! nicotine pouch brand, has rallied sharply after reporting third-quarter 2026 results and raising its full-year outlook. The question now on investors' minds is whether the dividend-paying tobacco giant can extend that momentum toward a round-number milestone of $85 per share.

Key Takeaways

  • The central target of $85 is not an analyst-consensus figure. It reflects a technical and psychological milestone above the 52-week high rather than the average of published analyst price targets.
  • The average analyst price target sits near $70, below the recent share price, so the analyst-based method could not be used; the $85 level is used here as a fallback objective.
  • With the stock recently closing near $76.75, reaching $85 would require a gain of roughly 11%, a substantial move.
  • Analyst targets span a wide range of roughly $58 to $83, signaling genuine disagreement about the durability of Altria's earnings growth.
  • Supporting factors include raised 2026 guidance, a 61st dividend increase in 57 years, an expanded buyback, and on! pouch volume growth; key risks are secular cigarette-volume declines, oral tobacco weakness, and regulatory pressure.
  • For more on this company, explore Major News, Today's Price Move, Forecast, and Earnings pages.
  • Discover additional tools and ideas by exploring Trending AI Robots.

Analyst Price Targets and Consensus View

The $85 objective is established through a fallback approach because the conventional analyst method does not work here. Aggregators report an average analyst price target near $69.90 to $70.55, which is below the stock's recent price of about $76.75, and even the highest individual targets sit only slightly above it. Because the mean of all valid targets is below the price, and the average of the few targets above the price still falls short of a meaningful 10% premium, no usable analyst consensus exists for this exercise.

For context, individual analyst price targets span roughly $58 to $83. UBS raised its target to $83 from $79 following the quarterly report and maintains a Buy rating, while Barclays and Citigroup hold more cautious views with targets near $63 and $65. Morgan Stanley carries an Equal Weight rating with a target near $71. The wide range reflects a fundamental disagreement: bullish analysts emphasize earnings visibility and stabilization in cigarette volume declines, while cautious analysts point to premium-share erosion and questions about how much investors should pay for a business in secular decline.

Current Market Position and Path Toward the Target

The stock recently closed near $76.75, close to its 52-week high of about $77, after gaining roughly 5% on strong quarterly results. Reaching $85 would require an additional gain of about 11% from that level, which qualifies as a substantial move for a large, mature consumer staples company with low single-digit earnings growth.

The plausible path toward $85 would require two things: first, a decisive breakout and hold above the prior 52-week high, which would clear the stock into multi-year high territory; and second, sustained upward revisions to earnings estimates as investors gain confidence that Altria's smoke-free transition and pricing power can offset cigarette-volume declines. Any move of that magnitude would likely need multiple expansion on the stock's price-to-earnings (P/E) ratio, which currently sits in the mid-teens.

What Could Support a Move Toward the Target

Altria reported third-quarter adjusted diluted earnings per share (EPS) of $1.52, up 4.8% year over year and above estimates, and raised full-year 2026 adjusted EPS guidance to a range of $5.66 to $5.74, implying 4.5% to 6% growth. Smokeable products delivered strong pricing, with Marlboro holding 60% share of the premium cigarette segment. The on! nicotine pouch brand grew shipment volume 13.3% year over year. The company also boosted its quarterly dividend 4.7% to $1.11 per share, expanded its share repurchase program by $1 billion, and continues to benefit from its stake in global brewer Anheuser-Busch InBev, whose equity earnings rose sharply.

What Could Prevent the Target From Being Reached

The core obstacle is the structural decline in cigarette consumption, with domestic cigarette shipment volume down 2.9% in the quarter. Price realization in the smokeable segment has slowed, and consumers are trading down toward discount brands amid economic pressure. The oral tobacco segment is a particular concern: adjusted operating income fell 3.7% as Copenhagen and Skoal volumes dropped sharply, and on! lost share within the fast-growing nicotine pouch category. Regulatory risk remains elevated, including litigation and Food and Drug Administration (FDA) review of vapor products, while illicit e-vapor competition continues to pressure the legal market.

Technical Levels and Market Structure

The stock is testing the top of its 52-week range, with the prior high near $77 acting as immediate resistance. A sustained break above that level would open the way toward the next psychological milestone at $85. On the downside, the prior breakout zone near $73 to $74 and the broader $68 to $70 area, where the average analyst target sits, represent key support levels. The long-term trend has improved as the stock has climbed from its 52-week low near $54.70.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms vary. Investors should watch the next quarterly earnings report for confirmation that cigarette-volume declines are stabilizing and that on! is converting shipments into genuine consumer demand. Also relevant are FDA and regulatory decisions on vapor products, changes to the dividend and buyback program, and any analyst target revisions following the guidance increase. Broader interest-rate conditions matter for an income-oriented stock, as lower yields tend to support demand for high-dividend equities.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and exchange-traded funds, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single indicator or a subjective read, the system is designed to help traders discover new opportunities, monitor existing positions, and spot shifting trends more efficiently. For investors tracking Altria's breakout potential, this tool can provide a useful, data-driven complement to fundamental and analyst research.

Final Assessment

The $85 target for Altria Group is a technical and psychological milestone rather than an analyst consensus, reflecting how far the stock has already risen. Reaching it would require an additional gain of roughly 11% from current levels — a substantial move that would likely depend on a durable breakout above the 52-week high and continued confidence in the smoke-free transition. Support comes from raised guidance, steady dividend growth, buybacks, and on! momentum, while the principal obstacles are secular volume decline, oral tobacco weakness, and regulatory uncertainty. The wide analyst range underscores that there is no consensus on whether the stock has further to run, and no outcome is guaranteed.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement

MO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MO has been loosely correlated with PM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MO jumps, then PM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MO
1D Price
Change %
MO100%
+0.33%
PM - MO
58%
Loosely correlated
-1.47%
BTI - MO
57%
Loosely correlated
+0.36%
UVV - MO
45%
Loosely correlated
-0.50%
TPB - MO
24%
Poorly correlated
-10.59%
RLX - MO
1%
Poorly correlated
-1.92%
More
Can Altria Group (MO) Stock Reach $85?